Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (861)	1/16/2000 1:13:00 AM
From: Larry Liebman	Respond to of 4474

I sold my warrants between 3 1/4 and 3 3/4 to diversify further, i.e., EMIS, MEDX, CEGE, GZMO. Sat mumbling for a moment as the bid hit 4 moments after I struck the ominous SEND command to Schwab. Sat back and remembered the warrants could have expired worthless on 12/31/99!!! I continue to hold a chunk of common. Berger's statement that an ARGENT partnership could rival the HMR-ARIA genomics deal would, IMHO, have a "material" impact on the price of this equity. Richard, I am intrigued by your assessment of the Sangamo "switch". As Sangamo is local to us, I wondered if you had a sense of their technology.